Abstract:Sensitive and accurate detection of tumor markers is critically essential for the early clinical diagnosis, treatment and prognosis of cancers. Surface-enhanced Raman spectroscopy (SERS) utilizes plasmonic nanomaterials to generate a strong surface plasmon resonance (SPR) effect in the visible to near-infrared region, such as silver and gold nanostructures. The SPR effect can significantly enhance the Raman signals of adsorbed molecules on the surface of nanostructures, allowing to gain the sensitive fingerprint information for the analyte itself or the Raman reporter. Benefitted from the superior properties of high sensitivity, good selectivity, fast and noninvasive analysis, SERS has attracted increasing interest and become a very promising technique for biological analysis. In comparison with other bioanalytical techniques, such as enzyme-linked immunosorbent assay, fluorescence and electrochemical methods, SERS possesses the following advantages: (1) SERS has an ultrahigh sensitivity, even down to single molecule level; (2) SERS can provide the intrinsic molecular fingerprint information, and the bandwidths of SERS peaks are usually very narrow; (3) SERS is suitable for long-term monitoring, because of the resistance of photobleaching and photodegradation; (4) non-invasive detection can be achieved with a low amount of sample and no preparation; (5) the interference of water is very weak, so biological samples can conveniently be detected in aqueous solutions; (6) various SERS-active nanostructures can be designed for multiplex detection. In this review, we provide an overview of recent advances in SERS technology for the detection of different tumor markers, including proteins, enzymes, nucleic acids, cells, tissues, gases and others. Great successes have been achieved by utilizing SERS, which can facilitate the fabrication of assays for tumor biomarkers. However, SERS has not been widely applied in clinical bioanalysis and biodiagnosis in the past over 40 years. SERS-based bioassay involves complex interactions between light, surface plasmon nanomaterials, and bioassay systems. It is difficult to obtain reproducible and reliable Raman spectroscopy data, which is one of the main bottlenecks in SERS bioassay, resulting in the deficiency of clinical and standardized applications. Therefore, there are still many efforts to be done to control the potential factors: (1) It is necessary to prepare a SERS substrate with high uniformity, high enhancement, clean, or/and to properly modify its surface; (2) the suitable Raman reporters and tags are selected to improve the biocompatibility and avoid unspecific adsorption, which can trap analytes in the “hot spots”; (3) biological samples are retained in their native state during the storage and pretreatment procedure to avoid irreversible degradation; (4) appropriate SERS detection conditions are performed, such as excitation wavelength, exposure time, and laser power, to obtain real detection information; (5) accurate biomolecule database are established for spectral assignments. By further improving these challenges, we anticipate the more widespread application of SERS-based assay in biomedicine and bioanalysis fields.

Label-free rapid identification of tumor cells and blood cells with silver film SERS substrate

Rapid Identification of Living Cancer Cells Based on Label-Free Surface-Enhanced Raman Spectroscopy

Precise diagnosis of tumor cells and hemocytes using ultrasensitive, stable, selective cuprous oxide composite SERS bioprobes assisted with high-efficiency separation microfluidic chips

An efficient strategy for circulating tumor cell detection: surface-enhanced Raman spectroscopy

Rapid and Label-Free Identification of Different Cancer Types Based on Surface-Enhanced Raman Scattering Profiles and Multivariate Statistical Analysis.

Novel Nitrocellulose Membrane Substrate for Efficient Analysis of Circulating Tumor Cells Coupled with Surface-Enhanced Raman Scattering Imaging.

Efficient Detection of Single Circulating Tumor Cell in Blood Using Raman Mapping Based on Aptamer-SERS Bio-Probe Coupled with Micropore Membrane Filtration.

Ultrahigh SERS activity of the TiO2@Ag nanostructure leveraged for accurately detecting CTCs in peripheral blood

Octahedral Silver Oxide Nanoparticles Enabling Remarkable SERS Activity for Detecting Circulating Tumor Cells

A novel dual-function SERS-based identification strategy for preliminary screening and accurate diagnosis of circulating tumor cells

Improved SERS Nanoparticles for Direct Detection of Circulating Tumor Cells in the Blood.

Label-free diagnosis of lung cancer with tissue-slice surface-enhanced Raman spectroscopy and statistical analysis

TiO2-based Surface-Enhanced Raman Scattering bio-probe for efficient circulating tumor cell detection on microfilter

A rapid and simple method for efficient capture and accurate discrimination of circulating tumor cells using aptamer conjugated magnetic beads and surface-enhanced Raman scattering imaging

Label-free Rapid Detection of Urinary Tumor Cells Based on Surface-Enhanced Raman Scattering and Deep Learning

Recent advances in surface-enhanced Raman spectroscopy for the detection of tumor markers

Large Laser Spot-Swift Mapping Surface-Enhanced Raman Scattering on Ag Nanoparticle Substrates for Liquid Analysis in Serum-Based Cancer Diagnosis

Rapid and precise detection of cancers via label-free SERS and deep learning

Highly Sensitive Sers Cytosensor Based on Catalytic Hairpin Assembly-Mediated Zipper-Like Structures

Synergistic Enhancement of Ultrahigh SERS Activity Via Cu2O@Ag Core-Shell Structure for Accurate Label-Free Identification of Breast Tumor Subtypes

Identification and distinction of non-small-cell lung cancer cells by intracellular SERS nanoprobes